These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 118551)

  • 1. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries.
    Fein JM; Flor WJ; Cohan SL; Parkhurst J
    J Neurosurg; 1974 Jul; 41(1):49-58. PubMed ID: 4210067
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of persistent cerebral smooth muscle contraction in response to whole blood.
    Linder M; Alksne JF
    Stroke; 1978; 9(5):472-7. PubMed ID: 100906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the effects of intrathecal papaverine in experimental vasospasm.
    Ogata M; Marshall BM; Lougheed WM
    J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys.
    Peerless SJ; Fox AJ; Komatsu K; Hunter IG
    Stroke; 1982; 13(4):473-9. PubMed ID: 7101347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
    Pluta RM; Oldfield EH; Boock RJ
    J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chronic cerebral vasospasm in dogs with milrinone.
    Khajavi K; Ayzman I; Shearer D; Jones SC; Levy JH; Prayson RA; Skibinski CI; Hahn JF; Chyatte D
    Neurosurgery; 1997 Feb; 40(2):354-62; discussion 362-3. PubMed ID: 9007870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental inhibition of serotonin by antibiotic: prevention of cerebral vasospasm.
    Zervas NT; Hori H; Rosoff CB
    J Neurosurg; 1974 Jul; 41(1):59-62. PubMed ID: 4209213
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage.
    Mayberg MR; Houser OW; Sundt TM
    J Neurosurg; 1978 Jan; 48(1):49-57. PubMed ID: 619024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
    Hara H; Nosko M; Weir B
    J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
    Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
    Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration by Iloprost of the vasospastic effects of endothelin-1 in rabbit cerebral vessels.
    Keskil IS; Baykaner MK; Sencer H; Ataoğlu O; Ilgit E; Erdoğan B; Ceviker N; Ercan ZS
    Neuroreport; 1994 May; 5(9):1089-92. PubMed ID: 7521681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
    Macdonald RL; Bassiouny M; Johns L; Sajdak M; Marton LS; Weir BK; Hall ED; Andrus PK
    Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrugation of cerebral vessels following subarachnoid hemorrhage: comparison of two experimental models of chronic cerebral vasospasm.
    Rickels E; Seifert V; Zumkeller M; Kunz U; Reale E
    Exp Neurol; 1990 Feb; 107(2):178-86. PubMed ID: 2303126
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone.
    Nishiguchi M; Ono S; Iseda K; Manabe H; Hishikawa T; Date I
    Neurosurgery; 2010 Jan; 66(1):158-64; discussion 164. PubMed ID: 20023546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture.
    Mizukami M; Takemae T; Tazawa T; Kawase T; Matsuzaki T
    Neurosurgery; 1980 Dec; 7(6):583-6. PubMed ID: 7207754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.